Powder: -20°C for 3 years | In solvent: -80°C for 1 year
2,6-Dihydroxybenzoic acid, a secondary metabolite derived from salicylic acid, undergoes hydrolyzation by liver enzymes as part of phase I metabolism.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 mg | In stock | $ 42.00 | |
5 g | In stock | $ 50.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 46.00 |
Description | 2,6-Dihydroxybenzoic acid, a secondary metabolite derived from salicylic acid, undergoes hydrolyzation by liver enzymes as part of phase I metabolism. |
Molecular Weight | 154.12 |
Formula | C7H6O4 |
CAS No. | 303-07-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (194.65 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
2,6-Dihydroxybenzoic acid 303-07-1 Metabolism Endogenous Metabolite 2,6 Dihydroxybenzoic acid 2,6Dihydroxybenzoic acid inhibit Inhibitor inhibitor